Literature DB >> 32531536

Should aspirin be used for prophylaxis of COVID-19-induced coagulopathy?

Aliae A R Mohamed-Hussein1, Karim M E Aly2, Mohamed-Eltaher A A Ibrahim3.   

Abstract

Entities:  

Year:  2020        PMID： 32531536     DOI： 10.1016/j.mehy.2020.109975

Source DB:  PubMed          Journal:  Med Hypotheses        ISSN： 0306-9877            Impact factor:   1.538


× No keyword cloud information.
  17 in total

1.  No association of low-dose aspirin with severe COVID-19 in France: A cohort of 31.1 million people without cardiovascular disease.

Authors:  Jérémie Botton; Laura Semenzato; Julie Dupouy; Rosemary Dray-Spira; Alain Weill; Olivier Saint-Lary; Mahmoud Zureik
Journal:  Res Pract Thromb Haemost       Date:  2022-06-17

2.  Electrospun Aspirin/Eudragit/Lipid Hybrid Nanofibers for Colon-targeted Delivery Using an Energy-saving Process.

Authors:  Yibin Wang; Liang Tian; Tianhao Zhu; Jing Mei; Zezhong Chen; Deng-Guang Yu
Journal:  Chem Res Chin Univ       Date:  2021-03-31       Impact factor: 1.307

3.  Comparative Anti-Inflammatory Effects of Salix Cortex Extracts and Acetylsalicylic Acid in SARS-CoV-2 Peptide and LPS-Activated Human In Vitro Systems.

Authors:  Nguyen Phan Khoi Le; Corinna Herz; João Victor Dutra Gomes; Nadja Förster; Kyriaki Antoniadou; Verena Karolin Mittermeier-Kleßinger; Inga Mewis; Corinna Dawid; Christian Ulrichs; Evelyn Lamy
Journal:  Int J Mol Sci       Date:  2021-06-23       Impact factor: 5.923

Review 4.  Cancer vs. SARS-CoV-2 induced inflammation, overlapping functions, and pharmacological targeting.

Authors:  Sreedhar Amere Subbarao
Journal:  Inflammopharmacology       Date:  2021-03-15       Impact factor: 5.093

5.  Targeting cyclooxygenase enzyme for the adjuvant COVID-19 therapy.

Authors:  Parteek Prasher; Mousmee Sharma; Ravi Gunupuru
Journal:  Drug Dev Res       Date:  2021-01-25       Impact factor: 5.004

6.  Does admission acetylsalicylic acid uptake in hospitalized COVID-19 patients have a protective role? Data from the Spanish SEMI-COVID-19 Registry.

Authors:  Francesc Formiga; Manuel Rubio-Rivas; José María Mora-Luján; Samara Campos Escudero; Rosa Fernandez Madera Martinez; Manuel Mendez-Bailón; Pedro Durán-Del Campo; Andrea Riaño Pérez; Francisco-Javier García-Sánchez; José Nicolás Alcalá-Pedrajas; Sergio Arnedo Hernández; Almudena Hernández Milian; Ana Latorre Díez; Ricardo Gil Sánchez; Ramon Boixeda; Julio Vicente; Begoña Cortes; Carmen Mella Pérez; María Esther Guisado Espartero; José López Castro; Santiago Rodríguez Suárez; Jose F Varona; Ricardo Gomez-Huelgas; Jose Manuel Ramos-Rincón
Journal:  Intern Emerg Med       Date:  2021-11-29       Impact factor: 5.472

Review 7.  Drug-based therapeutic strategies for COVID-19-infected patients and their challenges.

Authors:  Khatereh Zarkesh; Elaheh Entezar-Almahdi; Parisa Ghasemiyeh; Mohsen Akbarian; Marzieh Bahmani; Shahrzad Roudaki; Rahil Fazlinejad; Soliman Mohammadi-Samani; Negar Firouzabadi; Majid Hosseini; Fatemeh Farjadian
Journal:  Future Microbiol       Date:  2021-11-23       Impact factor: 3.165

8.  Tackling obesity during the COVID-19 pandemic.

Authors:  Amit Akirov; Avivit Cahn; Stefano Del Prato; Philip Home; Luc Van Gaal; Juliana Chan; Guang Ning; Itamar Raz
Journal:  Diabetes Metab Res Rev       Date:  2020-08-29       Impact factor: 8.128

Review 9.  COVID-19 and Panax ginseng: Targeting platelet aggregation, thrombosis and the coagulation pathway.

Authors:  Yuan Yee Lee; Yixian Quah; Jung-Hae Shin; Hyuk-Woo Kwon; Dong-Ha Lee; Jee Eun Han; Jin-Kyu Park; Sung Dae Kim; Dongmi Kwak; Seung-Chun Park; Man Hee Rhee
Journal:  J Ginseng Res       Date:  2022-01-19       Impact factor: 5.735

10.  Common drugs, vitamins, nutritional supplements and COVID-19 mortality.

Authors:  Steven Lehrer; Peter H Rheinstein
Journal:  Int J Funct Nutr       Date:  2021-03-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.